Literature DB >> 15451491

Pathogenesis of urinary tract infections with normal female anatomy.

Gal Finer1, Daniel Landau.   

Abstract

Recurrent urinary tract infections (UTIs) are common among girls and young women who are healthy and have anatomically normal urinary tracts. These infections are a main source of morbidity and health-care costs in this population. The interaction between specific infecting bacteria and urinary tract epithelium characteristics underlies the pathogenesis of this disease. Several pathogen-related factors predispose people to recurrent UTI, including periurethral bacterial colonisation and Escherichia coli virulence. Host behavioural risk factors include voiding dysfunction, high intercourse frequency, and oral contraceptive and spermicide use. The role of vesicoureteral reflux in recurrent childhood UTI is probably overestimated in the medical literature and is important only in a small group of children with high-grade reflux. Family pedigree analysis suggests a familial genetic predisposition for UTI among young females. Animal models show the multigenic nature of recurrent UTI. Putative candidate genes for the disease include ABH blood groups, interleukin-8 receptor (CXCR1), the human leucocyte antigen locus, toll-like receptors, tumour necrosis factor, and Tamm-Horsfall protein.

Entities:  

Mesh:

Year:  2004        PMID: 15451491     DOI: 10.1016/S1473-3099(04)01147-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  21 in total

Review 1.  [Recurrent urinary tract infections in women. Virulence of pathogens and host reaction].

Authors:  T Oelschlaeger; R Fünfstück
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

2.  Oral hormonal contraceptives affect the concentration and composition of urinary glycosaminoglycans in young women.

Authors:  Mary J G Zamboni; Carlos A P Cabral; Francisco J B Sampaio; Luiz E M Cardoso
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-07-04

3.  Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infections.

Authors:  Karen L Nielsen; Pia Dynesen; Preben Larsen; Lotte Jakobsen; Paal S Andersen; Niels Frimodt-Møller
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

4.  Cystitis treatment in women, circa 2011: new role for an old drug.

Authors:  Henry J Schultz; Randall S Edson
Journal:  Mayo Clin Proc       Date:  2011-06       Impact factor: 7.616

5.  Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections.

Authors:  Alex Smithson; Maria Rosa Sarrias; Juanjo Barcelo; Belen Suarez; Juan Pablo Horcajada; Sara Maria Soto; Alex Soriano; Jordi Vila; Jose Antonio Martinez; Jordi Vives; Jose Mensa; Francisco Lozano
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

6.  Rat strains differ in susceptibility to Ureaplasma parvum-induced urinary tract infection and struvite stone formation.

Authors:  Leticia Reyes; Mary Reinhard; L J O'donell; Janet Stevens; Mary B Brown
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

Review 7.  Probiotic therapy: immunomodulating approach toward urinary tract infection.

Authors:  Sarika Amdekar; Vinod Singh; Desh Deepak Singh
Journal:  Curr Microbiol       Date:  2011-09-07       Impact factor: 2.188

8.  Iha from an Escherichia coli urinary tract infection outbreak clonal group A strain is expressed in vivo in the mouse urinary tract and functions as a catecholate siderophore receptor.

Authors:  Simon Léveillé; Mélissa Caza; James R Johnson; Connie Clabots; Mourad Sabri; Charles M Dozois
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 9.  Genetic risk for recurrent urinary tract infections in humans: a systematic review.

Authors:  M Zaffanello; G Malerba; L Cataldi; F Antoniazzi; M Franchini; E Monti; V Fanos
Journal:  J Biomed Biotechnol       Date:  2010-03-30

10.  Abnormal immunological profile and vaginal microbiota in women prone to urinary tract infections.

Authors:  Pirkka V Kirjavainen; Stephen Pautler; Miren L Baroja; Kingsley Anukam; Kate Crowley; Kristine Carter; Gregor Reid
Journal:  Clin Vaccine Immunol       Date:  2008-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.